St. Louis Data Firm Launches Tools For Cancer Genome Analysis

A 3D Representation of the DNA Molecule and its alleles. | Photo Courtesy of Creative Commons
A 3D Representation of the DNA Molecule and its alleles. | Photo Courtesy of Creative Commons

St. Louis-based data analytics firm Appistry Inc. launched the Cancer Genome Analysis Suite, a set of tools to help analyze cancer data. The suite’s tools include the Broad Institute’s Genome Analysis Toolkit (GAKT), which Appistry has distributed since 2012, and MuTect, which is used for identifying somatic point mutations more accurately and precisely than most genetic analysis tools.

Appistry chief scientific officer Rich Mazzarella said in a statement that “tools like MuTect will help physicians track low allelic fraction mutations, tie these events to disease progression and treatment responses, and improve the way cancer is fought in individual patients.”

Employees at H3 Biomedicine, an oncology discovery company that recently purchased Appistry’s Cancer Genome Analysis Suite, said that using proven instruments like those in the suite will allow research efforts to be directed towards other needed analysis tools.

Read more from Business Wire


Tags:,

Leave a Reply

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students